Adverse Occurrence type:
Most recent risk assessment for Liver Cancer (Council of Europe, 2018): Active liver or biliary cancer is considered to represent an Unacceptable Risk for organ donation. Tumors that have been treated are considered High Risk. This risk may decrease for early stage tumors after curative therapy or recurrence-free time of at least >5 years with increasing probability of cure for long-term survivors.
Time to detection:
Alerting signals, symptoms, evidence of occurrence:
Demonstration of imputability or root cause:
Evaluated by OPTN/UNOS Disease Transmission Advisory Committee (DTAC) as confirmed transmission. (Transmission confirmed in 1 recipient from 3 donors)
Suggest new keywords:
Liver cancer, type not specified
Expert comments for publication:
Reported as part of update of UNOS data. Limited information regarding the specific case.